Your Messages Inbox
Your Article Summary
See Latest ArticlesCTI Focuses on Late-Stage Drug Approvals and Commercialization and Cuts Operating Costs: to Close Bresso Research Center
Cell Therapeutics, 03/02/09
Cell Therapeutics, Inc. announced that it has started a collective dismissal procedure pursuant to Law 223/1991 concerning its Bresso, Italy, employees. The collective dismissal will involve a total of 62 employees. Within 75 days of the consultation procedure, the company, in cooperation with the Trade Unions, will review solutions that may reduce the social impact of the decision.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Recombinant Human Erythropoietin, Epogin Injection
Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09
Synthon announces European approvals for Raloxifene
Synthon, 12/08/09
US FDA approves SEROQUEL for the pediatric treatment of schizophrenia and bipolar mania
AstraZeneca, 12/07/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Freeze-Thaw Performance and Robustness Assessment of Celsius FFT 6L
BioPharm, 12/09/09
Bivariate Random Effects Meta-Analysis of Diagnostic Studies Using Generalized Linear Mixed Models
Medical Decision Making, 12/09/09
The Impact of Disposables on Project Economics in a New Antibody Plant
BioPharm, 12/09/09
Article Search
Sponsor